Contemporary Trends, Characteristics, and Outcomes of Transcatheter Aortic Valve Implantation Among Extreme Elderly Patients.


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
01 07 2023
Historique:
received: 07 11 2022
revised: 04 04 2023
accepted: 13 04 2023
medline: 13 6 2023
pubmed: 18 5 2023
entrez: 17 5 2023
Statut: ppublish

Résumé

Transcatheter aortic valve implantation (TAVI) has been increasingly performed among extreme elderly patients with symptomatic severe aortic stenosis. We aimed to study the trends, characteristics, and outcomes of TAVI among extreme elderly. The National Readmission Database for the years 2016 to 2019 was queried for extreme elderly who underwent TAVI. Linear regression analysis was used to calculate the temporal trends in outcomes. A total of 23,507 TAVI extreme elderly admissions (50.3% women and 95.9% Medicare insurance) were included. The in-hospital mortality and all-cause 30-day readmissions were 2% and 15% and have been stable over years of analysis (p trend = 0.79 and 0.06, respectively). We evaluated complications, such as permanent pacemaker implantation (12%) and stroke (3.2%). Stroke rates did not decrease (3.4% vs 2.9% in 2016 and 2019 [p trend = 0.24]). The mean length of stay improved from 5.5 days in 2016 to 4.3 days in 2019 (p trend <0.01). The rates of early discharge (day ≤3) has improved from 49% in 2016 to 69% in 2019 (p trend <0.01). In conclusion, this nationwide contemporary observational analysis showed that TAVI was associated with low rates of complications in the extreme elderly.

Identifiants

pubmed: 37196531
pii: S0002-9149(23)00229-1
doi: 10.1016/j.amjcard.2023.04.019
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

33-35

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Auteurs

Wael Abdelmottaleb (W)

Metropolitan Hospital Center, Department of Medicine, New York Medical College, New York City, New York. Electronic address: w.abdelmottaleb@gmail.com.

Ahmed Maraey (A)

Department of Internal Medicine, Carle Foundation, Urbana, Illinois.

Mustafa Ozbay (M)

Metropolitan Hospital Center, Department of Medicine, New York Medical College, New York City, New York.

Rachel Royfman (R)

University of Toledo College of Medicine and Life Sciences, Toledo, Ohio.

Hadeer Elsharnoby (H)

Department of Internal Medicine, Carle Foundation, Urbana, Illinois.

Mahmoud Khalil (M)

Department of Internal Medicine, Lincoln Hospital, Bronx, New York.

Ahmed Elzanaty (A)

Department of Cardiovascular Medicine, University of Toledo, Toledo, Ohio.

Islam Y Elgendy (IY)

Division of Cardiovascular Medicine, Gill Heart Institute, University of Kentucky, Lexington, Kentucky.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH